Lori Shutter, MD, FNCS, FCCM

Professor of Neurology

Title(s)

  • Vice Chair, Education, Department of Critical Care Medicine
  • Director, Neurocritical Care Fellowship Program
  • Medical Director, Neurovascular & Neurotrauma ICUs

Biographical Sketch

Dr. Shutter is the Vice Chair for Education in the Department of Critical care Medicine, directs the Multidisciplinary Critical Care Fellowship Training Program, serves as medical director of the Neurovascular and Neurotrauma ICUs, and leads the development of the Neurocritical Care (NCC) Program. Her clinical work is primarily in the Neurovascular and Neurotrauma ICUs where she cares for patients with stroke, subarachnoid hemorrhage, status epilepticus, and traumatic brain injury.

Dr. Shutter has also been participating in the Hedwig van Ameringen Executive Leadership in Academic Medicine (ELAM) Fellowship. This prestigious and highly competitive program provided her with intensive leadership training that included extensive coaching, networking and mentoring opportunities aimed at expanding the national pool of qualified women candidates for leadership in academic medicine, dentistry, and public health. She received a Presidential Citation from the Neurocritical Care Society and was named Faculty of the Year by the fellows in the Department of Critical Care Medicine.

She has led efforts to strengthen collaborative relationships between critical care and the neurosciences through educational activities, the creation of clinical practice guidelines, and facilitating quality improvement and research activities. Dr. Shutter continues her work with the Neurology Residency Curriculum Committee, as well as the educational training and rotations in NCC for the Neurology Residency Training Program. She continues to actively mentor neurology residents who are interested in NCC fellowship training.

NCC research activities occur both on an individual level and through collaborations with Neurosurgery, Neurology and Emergency Medicine. Current projects in which Dr. Shutter has a leadership role include SHINE to evaluate glucose control methods after stroke, Neurological Emergencies Treatment Trial (NETT) Network, and a study looking at goal-directed management of neurocardiac injury after subarachnoid hemorrhage.